Lifelong Wealth Advisors’s AbbVie ABBV Stock Holding History

Lifelong Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$433K	Buy	1,719 +27	+2%	+$5.81K	0.1%	66
2026 Q1	$368K	Hold	1,692	–	–	0.1%	67
2025 Q4	$387K	Buy	1,692 +9	+0.5%	+$2.05K	0.1%	63
2025 Q3	$390K	Buy	1,683 +238	+16%	+$48.5K	0.12%	56
2025 Q2	$268K	Buy	1,445 +24	+2%	+$4.46K	0.09%	67
2025 Q1	$298K	Buy	1,421 +35	+3%	+$6.8K	0.14%	52
2024 Q4	$246K	Buy	+1,386	New	+$255K	0.11%	57

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lifelong Wealth Advisors's ABBV Position: Q2 2026 in Review

Lifelong Wealth Advisors increased its AbbVie (ABBV) stake by 1.6% in Q2 2026, buying an estimated $5.81K and bringing the position to 1,719 shares worth $433K. The position accounts for 0.1% of the portfolio, ranked #66.

Lifelong Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Lifelong Wealth Advisors held 1,719 shares of AbbVie worth $433K as of Q2 2026.
Lifelong Wealth Advisors bought 27 AbbVie shares in Q2 2026, an estimated $5.81K.
AbbVie made up 0.1% of Lifelong Wealth Advisors's portfolio in Q2 2026, its #66 holding.
Lifelong Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lifelong Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.